Bilateral Oophorectomy versus Ovarian Conservation: Effects on Long-term Women's Health

被引:78
作者
Parker, William H. [1 ]
机构
[1] St Johns Hlth Ctr, John Wayne Canc Inst, Santa Monica, CA 90401 USA
关键词
Oophorectomy; Ovarian conservation; Hysterectomy; Coronary heart disease; Stroke; Lung cancer; Ovarian cancer; Breast cancer; Women's health; REPLACEMENT THERAPY; UNDERWENT OOPHORECTOMY; PREMENOPAUSAL WOMEN; HORMONE-THERAPY; INCREASED RISK; HEART-DISEASE; FRACTURE RISK; HIP FRACTURE; MENOPAUSE; ESTROGEN;
D O I
10.1016/j.jmig.2009.12.016
中图分类号
R71 [妇产科学];
学科分类号
100211 [妇产科学];
摘要
Bilateral oophorectomy at the time of hysterectomy for benign disease is commonly practiced to prevent the subsequent development of ovarian cancer. Currently, bilateral oophorectomy is performed in 55% of all U.S. women having a hysterectomy, with approximately 300 000 prophylactic oophorectomies performed every year. Observational studies show that estrogen deficiency, resulting from premenopausal or postmenopausal oophorectomy, is associated with higher risks of coronary artery disease, stroke, hip fracture, Parkinsonism, dementia, cognitive impairment, depression, and anxiety. These studies suggest that bilateral oophorectomy may do more harm than good. In women not at high risk for development of ovarian or breast cancer, removing the ovaries at the time of hysterectomy should be approached with caution. Journal of Minimally Invasive Gynecology (2010) 17,161-166 (c) 2010 AAGL. All rights reserved.
引用
收藏
页码:161 / 166
页数:6
相关论文
共 57 条
[1]
[Anonymous], SEER Cancer Statistics Review 1975-2008
[2]
Postmenopausal bilateral oophorectomy is not associated with increased fracture risk in older women [J].
Antoniucci, DM ;
Sellmeyer, DE ;
Cauley, JA ;
Ensrud, KE ;
Schneider, JL ;
Vesco, KK ;
Cummings, SR ;
Melton, LJ .
JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (05) :741-747
[3]
Hormone replacement therapy and life expectancy after prophylactic oophorectomy in women with BRCA1/2 mutations:: A decision analysis [J].
Armstrong, K ;
Schwartz, JS ;
Randall, T ;
Rubin, SC ;
Weber, B .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (06) :1045-1054
[4]
Caffeine, postmenopausal estrogen, and risk of Parkinson's disease [J].
Ascherio, A ;
Chen, H ;
Schwarzschild, MA ;
Zhang, SM ;
Colditz, GA ;
Speizer, FE .
NEUROLOGY, 2003, 60 (05) :790-795
[5]
Bachmann GA, 2000, AM FAM PHYSICIAN, V61, P3090
[6]
The malignant potential of small cystic ovarian tumors in women over 50 years of age [J].
Bailey, CL ;
Ueland, FR ;
Land, GL ;
DePriest, PD ;
Gallion, HH ;
Kryscio, RJ ;
van Nagell, JR .
GYNECOLOGIC ONCOLOGY, 1998, 69 (01) :3-7
[7]
Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: An exploratory case-control study [J].
Benedetti, MD ;
Maraganore, DM ;
Bower, JH ;
McDonnell, SK ;
Peterson, BJ ;
Ahlskog, JE ;
Schaid, DJ ;
Rocca, WA .
MOVEMENT DISORDERS, 2001, 16 (05) :830-837
[8]
CHRIST JE, 1975, OBSTET GYNECOL, V46, P551
[9]
MENOPAUSE AND THE RISK OF CORONARY HEART-DISEASE IN WOMEN [J].
COLDITZ, GA ;
WILLETT, WC ;
STAMPFER, MJ ;
ROSNER, B ;
SPEIZER, FE ;
HENNEKENS, CH .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (18) :1105-1110
[10]
De Aloysio D, 2000, MATURITAS, V36, P19